BinD-19

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF
Applicant: THE US SECRETARY DEPT OF HEALTH AND HUMANPriority: 2023
US
ANTIBODIES AGAINST SARS-COV-2 S1 SPIKE PROTEIN
Applicant: ACTIVE MOTIF SHANGHAI LTDPriority: 2020
WO
Antibody agents specific for human CD19 and uses thereof
Applicant: EUREKA THERAPEUTICS INCPriority: 2017
US
2 publications
Bi-specific cd3 and cd19 antigen-binding constructs
Applicant: ZYMEWORKS INCPriority: 2014
CN
SARS-COV2 ANTIBODIES
Applicant: IONTAS LTDPriority: 2020
WO
METHODS OF PRODUCING ANTI-CD19 ANTIBODIES
Applicant: ZENAS BIOPHARMA INCPriority: 2024
WO
CD19 ANTIBODIES AND METHODS OF USING THE SAME
Applicant: MEMORIAL SLOAN KETTERING CANCER CENTERPriority: 2019
EP
US
WO
4 publications
ANTI-CD19 ANTIBODIES AND MULTI-SPECIFIC BINDING PROTEINS
Applicant: CULLINAN ONCOLOGY INCPriority: 2019
EP
US
2 publications